At Fetse Lab, we are pioneering the development of peptide-based platforms for efficient and targeted gene delivery. By harnessing the unique properties of peptides - biocompatibility, biodegradability, and receptor-mediated targeting - we design advanced delivery systems that enhance the stability and cellular uptake of genetic cargo, including mRNA, siRNA, and gene-editing tools. Our research focuses on engineering peptide-modified nanocarriers to improve gene therapy outcomes, particularly for neurological disorders, cancer, and cardiovascular diseases. We aim to develop next-generation gene delivery platforms that are safer and more effective for clinical applications.